Image-guided radiation for brain tumors that protects thinking
Part of Brain & nervous system, Cancer, Genetic & congenital, Heart & circulation clinical trials.
This trial tests a special type of radiation therapy for brain tumors that aims to protect your memory and thinking skills. It may be an option if you have certain brain tumors or a small number of brain metastases.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have a brain tumor type that can be treated with focused radiation, such as limited brain metastases, a meningioma, or an AVM.
- You are generally able to care for yourself (ECOG score 0-2).
- You can answer questions and follow instructions for memory tests.
- You are expected to live more than 6 months.
- If you have brain metastases, you must have a confirmed cancer elsewhere in the body (like lung, breast, or prostate).
- You are willing and able to have MRI scans of the brain.
- You are not pregnant or breastfeeding, and if you could become pregnant, you agree to use birth control.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 2 trial tests a type of focused radiation (stereotactic radiosurgery, or SRS) for people with small cell lung cancer that has spread to the brain. It looks at whether this approach can treat brain metastases when the cancer has limited to a certain number of spots.
This study tests a type of radiation called stereotactic radiosurgery (SRS) given right after surgery to remove a brain tumor. The goal is to see if it helps control the tumor with fewer side effects.
This study tests a type of radiation treatment for people with one or more brain tumors that are larger than usual (2 to 5 centimeters). It aims to see if this approach is safe and effective, and may be an option if you are not having immediate surgery.
This study tests a more targeted form of stereotactic (precise) brain radiation for people with brain metastases from large cell cancer. It aims to improve the balance between effectiveness and side effects by carefully focusing where the radiation goes.
This Phase 2 study tests a precise, no-head-frame radiation technique to treat brain metastases. It may help by aiming radiation tightly at the tumors while limiting exposure to nearby healthy brain.
This trial tests a special type of whole-brain radiation that aims to avoid the parts of the brain that control memory. It's for people with many brain tumors (6 or more) that haven't been treated with radiation before.
Hear when a new Brain Metastases, Adult trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.